Med-Life Discoveries

Focus: Med-Life Discoveries is a public biotechnology company headquartered in Saskatoon, Canada, focused on plasmalogen therapies for rare genetic disorders. The company is in early-stage development with a single Phase 1 program.

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Funding Stage

PUBLIC

Open Jobs

About Med-Life Discoveries

AI assessmentNot Hiring

No open roles listed right now. Follow Med-Life Discoveries to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

RCDP Natural History Study

Rhizomelic Chondrodysplasia Punctata

N/A

Clinical Trials (1)

NCT04031287RCDP Natural History Study

N/A

Help build intelligence for Med-Life Discoveries

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work on rare disease therapies addressing unmet medical needs in rhizomelic chondrodysplasia punctata (RCDP)
Early-stage biotech environment with potential for significant scientific contribution and career growth if pipeline advances
Specialized focus on plasmalogen biology represents a differentiated therapeutic approach with limited competitive saturation

Watch Out For

No active hiring (0 open positions) indicates limited near-term employment opportunities across all departments
Pre-revenue stage with only Phase 1 data means significant technical and commercial risk; uncertain path to value realization
Missing critical financial data (funding, cash position, revenue) prevents assessment of runway and sustainability

Generated by Claude from Med-Life Discoveries's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

PPI-1011

Rhizomelic Chondrodysplasia Punctata

Phase 1

Clinical Trials (1)

NCT05969977A First-in-Human Phase 1 Study of Plasmalogen Precursor PPI-1011 in Healthy Adult Volunteers to Assess Safety, Tolerability, and Pharmacokinetics

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo